Drug Chatter -- Tracking biopharma stock chatter

💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…

Profile for Karyopharm Therapeutics Inc. (KPTI)

« Back to company index

KPTI Chatter Timeline

Stock Ticker for KPTI

Most Active Tweeters for KPTI

UserTweets
@Tickeron 4
@Jarvis_Alerts 4
@VapzerSignals 4
@Rajt1111 3
@phasefivebot 3

Recent Tweets for KPTI

formwhisperscom @formwhisperscom
#FWSells $KPTI Mitchener Stephen, SVP, Chief Business Officer of Karyopharm Therapeutics Inc. sold 499 shares on 20… https://t.co/DaVDw8Askm
4:12am
InsiderForms @InsiderForms
$KPTI Insider Mitchener Stephen has Sold 499 Shares. Title :SVP Chief Business Officer Total Cost: $3,338.31 Buy/S… https://t.co/fNuwx5HUEM
December 3rd 2021, 11:12pm
FlashAlert_me @FlashAlert_me
$KPTI [15s. delayed] filed SEC form 4: SVP, Chief Business Officer Mitchener Stephen: Disposed 499 of Common Stock… https://t.co/4cl2sJxAr8
December 3rd 2021, 11:12pm
A1Syad @A1Syad
$KPTI Awaiting Buy Signal. Stock Trading Ideas by https://t.co/1MjnDHV7ua https://t.co/IFsfYvll8s
December 3rd 2021, 6:12pm
fda_tracker @fda_tracker
$KPTI Phase 2 trial w/est Dec completion date NCT03193437: https://t.co/Uz2barqj4u Trial Tracker: https://t.co/aR7q5oJwjn
December 3rd 2021, 2:12pm
Jarvis_Alerts @Jarvis_Alerts
$KPTI 7.5C Exp:20-May-22 ? ? Total(Day): $66,336 #UnusualActivity Sign-up free for beta ver.:… https://t.co/xU7j3TWJpf
December 3rd 2021, 1:12pm
TedStamos @TedStamos
RT @_B_I_O_T_E_C_H_: $KPTI Selinexor #orphan designation for Treatment of glioblastoma https://t.co/davvtBzXdq
December 3rd 2021, 12:12pm
Gambiste1 @Gambiste1
RT @vtmtrading: Compass Pathways appoints Michael Falvey as Chief Financial Officer $CMPS $KPTI
December 3rd 2021, 12:12pm
vtmtrading @vtmtrading
Compass Pathways appoints Michael Falvey as Chief Financial Officer $CMPS $KPTI
December 3rd 2021, 12:12pm
1stOncology @1stOncology
#Karyopharm to Host Virtual Investor Day on December 8, 2021 $KPTI https://t.co/RLL2tzTTgR
December 3rd 2021, 8:12am
_B_I_O_T_E_C_H_ @_B_I_O_T_E_C_H_
$KPTI Selinexor #orphan designation for Treatment of glioblastoma https://t.co/davvtBzXdq
December 3rd 2021, 7:12am
pvenkiraju @pvenkiraju
RT @42Stocks: 2021-DEC-02 5:00pm $KPTI #Karyopharm Therapeutics up 8.82% = $46.3 million gain. https://t.co/yq1IFI5G7G (Dec 01) Karyopharm…
December 3rd 2021, 4:12am
pvenkiraju @pvenkiraju
RT @Jarvis_Alerts: $KPTI 7.5C Exp:20-May-22 ? ? Total(Day): $66,336 #UnusualActivity Sign-up free for beta ver.:https://t.co/WnUoHPObTm…
December 3rd 2021, 4:12am
Rajt1111 @Rajt1111
@terp2007 @Kevin_W81 My 2 sense is, there is no way $KPTI is not bought by June 22. Too valuable in the hands of big players…
December 2nd 2021, 10:12pm
Jarvis_Alerts @Jarvis_Alerts
$KPTI 7.5C Exp:20-May-22 ? ? Total(Day): $66,336 #UnusualActivity Sign-up free for beta ver.:… https://t.co/RPtK7TY36T
December 2nd 2021, 10:12pm
42Stocks @42Stocks
2021-DEC-02 5:00pm $KPTI #Karyopharm Therapeutics up 8.82% = $46.3 million gain. https://t.co/yq1IFI5G7G (Dec 01)… https://t.co/2DkHFW3LIX
December 2nd 2021, 10:12pm
sv_capitalhldg @sv_capitalhldg
RT @Karyopharm: Karyopharm $KPTI Completes Patient Recruitment in Phase 3 SIENDO Study of Selinexor in Patients with Endometrial Cancer. Le…
December 2nd 2021, 3:12pm
vtmtrading @vtmtrading
Karyopharm's selinexor granted FDA orphan designation for glioblastoma $KPTI
December 2nd 2021, 2:12pm
mehabecapital @mehabecapital
$KPTI @ 6.84 (+4.63%) : Karyopharm completes patient recruitment in late-stage selinexor study in endometrial cancer https://t.co/y06jk0bCp8
December 2nd 2021, 2:12pm
StckPro @StckPro
$KPTI NEW ARTICLE : Karyopharm Therapeutics (KPTI) Gets a Buy Rating from H.C. Wainwright https://t.co/KNPmpI2OTr G… https://t.co/qtWxIwvmXi
December 2nd 2021, 2:12pm
MarketCurrents @MarketCurrents
$KPTI - Karyopharm completes patient recruitment in late-stage selinexor study in endometrial cancer https://t.co/8oa2DVXwR7
December 2nd 2021, 2:12pm
MarcJacksonLA @MarcJacksonLA
$KPTI Karyopharm Completes Patient Recruitment in Phase 3 SIENDO Study of Selinexor in Patients with Endometrial Ca… https://t.co/IcVJJvemEG
December 2nd 2021, 2:12pm
MLEABUFF @MLEABUFF
Karyopharm $KPTI Completes Patient Recruitment in Phase 3 SIENDO Study of Selinexor in Patients with Endometrial Ca… https://t.co/WzTaqvHNQV
December 2nd 2021, 2:12pm
Karyopharm @Karyopharm
Karyopharm $KPTI Completes Patient Recruitment in Phase 3 SIENDO Study of Selinexor in Patients with Endometrial Ca… https://t.co/dILxrTGPnO
December 2nd 2021, 1:12pm
sv_capitalhldg @sv_capitalhldg
RT @BioStocks: $KPTI Completes Patient Recruitment in Phase 3 SIENDO Study of Selinexor in Patients with Endometrial Cancer. Topline Data b…
December 2nd 2021, 1:12pm
ChartMill @ChartMill
$KPTI was analyzed by 16 analysts. The buy consensus is at 79%. So analysts seem to be mildly confident about $ ...… https://t.co/5KyvHOkFXu
December 2nd 2021, 1:12pm
GeorgeB14941177 @GeorgeB14941177
$KPTI Karyopharm Completes Patient Recruitment in Phase 3 SIENDO Study of Selinexor in Patients with Endometrial… https://t.co/fahGrOKoOr
December 2nd 2021, 1:12pm
vtmtrading @vtmtrading
Karyopharm completes patient recruitment in Phase 3 endometrial cancer study $KPTI
December 2nd 2021, 12:12pm
bthefirsttoknow @bthefirsttoknow
First out// $KPTI: Karyopharm Completes Patient Recruitment In Phase 3 SIENDO Study Of Selinexor In Patients With Endometrial
December 2nd 2021, 12:12pm
FlashAlert_me @FlashAlert_me
$KPTI [15s. delayed]: Issued Press Release on December 02, 07:00:00: Karyopharm Completes Patient Recruitment in Ph… https://t.co/1BWCk1c345
December 2nd 2021, 12:12pm
BioStocks @BioStocks
$KPTI Completes Patient Recruitment in Phase 3 SIENDO Study of Selinexor in Patients with Endometrial Cancer. Topli… https://t.co/yRLz0utLe2
December 2nd 2021, 12:12pm
FrnkTss @FrnkTss
$KPTI Karyopharm Completes Patient Recruitment in Phase 3 SIENDO Study of Selinexor in Patients with Endometrial Ca… https://t.co/0CUgKphHuO
December 2nd 2021, 12:12pm
StockNewsBot2 @StockNewsBot2
$KPTI Karyopharm Completes Patient Recruitment in Phase 3 SIENDO Study of Selinexor in Patients with Endometrial Ca… https://t.co/R3Qt4ziV9P
December 2nd 2021, 12:12pm
quantisnow @quantisnow
$KPTI ? Karyopharm Completes Patient Recruitment in Phase 3 SIENDO Study of Selinexor in Patients with Endometrial… https://t.co/1gXl28CUeY
December 2nd 2021, 12:12pm
stock_titan @stock_titan
$KPTI Karyopharm Completes Patient Recruitment in Phase 3 SIENDO Study of Selinexor in Patients with Endometrial Ca… https://t.co/tB3vWuaVme
December 2nd 2021, 12:12pm
phasefivebot @phasefivebot
$KPTI Karyopharm Completes Patient Recruitment in Phase 3 SIENDO Study of Selinexor in Patients with Endometrial Ca… https://t.co/DVqqgOyIyB
December 2nd 2021, 12:12pm
newsfilterio @newsfilterio
Karyopharm to Host Virtual Investor Day on December 8, 2021 $KPTI https://t.co/Jv6Xqqb1Kc
December 2nd 2021, 7:12am
newsfilterio @newsfilterio
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635 $KPTI https://t.co/R39P071tVA
December 2nd 2021, 1:12am
Tickeron @Tickeron
$KPTI in Downtrend: RSI indicator exits overbought zone. View odds for this and other indicators:… https://t.co/SIyd0BJqxd
December 2nd 2021, 1:12am
Gambiste1 @Gambiste1
RT @phasefivebot: $KPTI Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://t.co/u6nUjq7PKA
December 1st 2021, 9:12pm
StockNewsBot2 @StockNewsBot2
$KPTI Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://t.co/Q9VtRhRURh
December 1st 2021, 9:12pm
quantisnow @quantisnow
$KPTI ? Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)… https://t.co/Zs6uRgIEeH
December 1st 2021, 9:12pm
stock_titan @stock_titan
$KPTI Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://t.co/L0i1t95YYQ
December 1st 2021, 9:12pm
phasefivebot @phasefivebot
$KPTI Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://t.co/u6nUjq7PKA
December 1st 2021, 9:12pm
MarcJacksonLA @MarcJacksonLA
$KPTI Karyopharm to Host Virtual Investor Day on December 8, 2021 https://t.co/MLlPeImpRW
December 1st 2021, 3:12pm
Rajt1111 @Rajt1111
@TedStamos @AdamSinger Of these 3, I think $KPTI will bring home not just the bacon but Farm... Massive potential..… https://t.co/tcDyW3IAmE
December 1st 2021, 2:12pm
Karyopharm @Karyopharm
Karyopharm $KPTI to Host Virtual Investor Day on December 8, 2021 at 10:00am ET. Learn more about participating th… https://t.co/nDBMjrba1b
December 1st 2021, 1:12pm
StockNewsBot2 @StockNewsBot2
$KPTI Karyopharm to Host Virtual Investor Day on December 8, 2021 https://t.co/3Bzp944S0N
December 1st 2021, 12:12pm
stock_titan @stock_titan
$KPTI Karyopharm to Host Virtual Investor Day on December 8, 2021 https://t.co/lRD1EgKGRF
December 1st 2021, 12:12pm
phasefivebot @phasefivebot
$KPTI Karyopharm to Host Virtual Investor Day on December 8, 2021 https://t.co/dFbHdqO9aR
December 1st 2021, 12:12pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2021. All rights reserved.